JO

Rating #113

Johnson & Johnson

Johnson & Johnson

Portfolio value

$503.70M

Stocks

20

Performance

1 Year

+22.55%

Stock Holdings

$

%

1Y

3Y

5Y

10Y

Johnson & Johnson’s Portfolio: Q3 2025

Top10 stocks: 97.20% of the portfolio

Johnson & Johnson’s Trades: Q3 2025

Adds

New Buys

Sold Outs

Cuts

no data

No trading activity

Johnson & Johnson’s Holdings: Q3 2025

Company Name
Primary Industry
Avg. price paid
sort
Share Count Chg. (%)
sort
No of shares held
sort
Market value
sort
Portfolio % Change
sort
% of Ownership
sort
Holding period
sort
Last Transaction
Pharmaceutical Pres
$17.72

0.00%

2.45M
$162.70M

32.30%

-8.52ppt

3.86%
17 Quarters
Q3 2021
Pharmaceutical Pres
$7.53

0.00%

5.62M
$106.23M

21.09%

13.47ppt

11.86%
9 Quarters
Q4 2023
Biological products
$9.43

0.00%

6.64M
$54.66M

10.85%

-2.29ppt

8.24%
17 Quarters
Q4 2022
Pharmaceutical Pres
$25.44

-28.56%

1.78M
$53.00M

10.52%

1.98ppt

0.50%
6 Quarters
Q3 2025
Surgical Instruments
$16.75

0.00%

4.10M
$33.11M

6.57%

-0.57ppt

15.74%
17 Quarters
Q1 2024
Pharmaceutical Pres
$50.56

0.00%

814.59K
$26.56M

5.27%

-3.17ppt

0.88%
17 Quarters
Q2 2023
Pharmaceutical Pres
$21.00

0.00%

1.98M
$23.26M

4.62%

2.18ppt

7.64%
6 Quarters
Q2 2024
Surgical Instruments
$38.15

0.00%

357.94K
$12.77M

2.54%

-3.56ppt

0.65%
17 Quarters
Q4 2022
Pharmaceutical Pres
$40.12

0.00%

748.06K
$8.77M

1.74%

-0.08ppt

1.01%
16 Quarters
Q4 2021
Pharmaceutical Pres
$62.43

0.00%

247.60K
$8.54M

1.70%

0.50ppt

0.18%
17 Quarters
Q3 2022
Biological products
$59.27

0.00%

3.38M
$4.26M

0.85%

-0.21ppt

2.85%
17 Quarters
Q3 2021
Biological products
$15.60

0.00%

1.85M
$3.37M

0.67%

0.25ppt

1.14%
9 Quarters
Q4 2023
Biological products
$48.72

+100.00%

53.73K
$2.62M

0.52%

0.52ppt

0.80%
1 Quarter
Q3 2025
Pharmaceutical Pres
$1.36

0.00%

3.64M
$1.81M

0.36%

-0.00ppt

8.11%
6 Quarters
Q2 2024
Pharmaceutical Pres
$16.24

+100.00%

41.17K
$668.52K

0.13%

0.13ppt

0.28%
1 Quarter
Q3 2025
X-Ray Apparatus
$11.10

0.00%

158.85K
$587.75K

0.12%

-0.13ppt

0.25%
16 Quarters
Q1 2024
Lab Analytical Instruments
$2.70

0.00%

311.97K
$405.56K

0.08%

-0.03ppt

0.08%
7 Quarters
Q1 2024
Pharmaceutical Pres
$7.84

0.00%

364.47K
$295.30K

0.06%

-0.01ppt

0.40%
17 Quarters
Q1 2024
Biological products
$3.06

0.00%

96.87K
$50.86K

0.01%

-0.00ppt

0.31%
17 Quarters
Q4 2024
Industrial Instruments
$3.39

0.00%

54.62K
$23.80K

0.01%

-0.00ppt

0.01%
17 Quarters
Q3 2021
gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2026 Gainify. All rights reserved.